Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Journal of Natural Products|August 12, 2011
Viridaphin A₁ glucoside, a green pigment possessing cytotoxic and antibacterial activity from the aphid Megoura crassicaudaMitsuyo Horikawa, To-Sho Hoshiyama, Masako Matsuzawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 18, 2002
[Multidisciplinary therapy for peritoneal dissemination using peritonectomy]Yutaka Yonemura, Kazuo Kinoshita, Shigeru Takahashi, et al.
Nature Cell Biology|May 27, 2003
MKP3 mediates the cellular response to FGF8 signalling in the vertebrate limbYasuhiko Kawakami, Joaquín Rodríguez-León, Christopher M Koth, et al.
Cancer Medicine|August 29, 2023
First-line nivolumab, paclitaxel, carboplatin, and bevacizumab for advanced non-squamous non-small cell lung cancer: Updated survival analysis of the ONO-4538-52/TASUKI-52 randomized controlled trialHye Ryun Kim, Shunichi Sugawara, Jong-Seok Lee, et al.
BMC Medical Education|November 19, 2014
A proposed core curriculum for dental English education in JapanOmar M M Rodis, Edward Barroga, J Patrick Barron, et al.
Cancer Science|January 29, 2026
Four-Year Outcomes for Nivolumab With Chemotherapy and Bevacizumab in Patients With Nonsquamous NSCLC in the TASUKI-52Jong-Seok Lee, Shunichi Sugawara, Jin-Hyoung Kang, et al.
Lung Cancer (Amsterdam, Netherlands)|February 2, 2025
First-line nivolumab plus platinum chemotherapy and bevacizumab for advanced nonsquamous non-small cell lung cancer: A 3-year follow-up of the phase 3 randomized TASUKI-52 trialKi Hyeong Lee, Jong-Seok Lee, Shunichi Sugawara, et al.
Pageof 10